Eric H. Bernicker, MD

  • 639 Citations
  • 10 h-Index
1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Personal profile

Dr. Bernicker earned his medical degree from Baylor College of Medicine in Houston, TX in 1990. Subsequently, he completed his residency at Baylor Affiliated Hospitals and was chief medical resident at Ben Taub General Hospital from 1993–1994. Dr. Bernicker held a faculty appointment at Baylor College of Medicine as a clinical assistant professor from 1996–2012 before joining the Houston Methodist Cancer Center in January 2013, where he serves as director of Medical Thoracic Oncology. As a physician-scientist, Dr. Bernicker oversees the expansion of clinical trials at The Methodist Hospital relating to Thoracic Oncology with all stages of disease, a combination of SWOG trials, and industry trials of novel targeted agents. 

Research interests

Dr. Bernicker’s research focuses on looking at different therapeutic approaches, such as targeted therapies and immunotherapies, in the treatment of lung cancer. By understanding how to identify patients at risk for relapse after surgery or those who can be spared the toxicities of chemotherapy, the immune system can be stimulated to preferentially destroy tumor cells, spare normal tissues, and improve patient survival along with the development of less toxic therapeutics. Eventually, the goal is to be able to offer new therapies and clinical trials to patients at Methodist with any stage of non-small cell lung cancer or small cell lung cancer.

Education/Academic qualification

Medical Oncology, Clinical Fellowship, Baylor College of Medicine

Jul 1 1994Sep 30 1996

Award Date: Sep 30 1996

MD, Baylor College of Medicine

May 1 1990Jun 1 1994

Award Date: Jun 1 1994

Internal Medicine, Residency, Baylor College of Medicine

Jan 1 1991Jun 30 1993

Award Date: Jun 30 1993

Internship, Dallas County Hospital -Parkland Memorial Hospital

Jan 1 1990Jan 1 1991

Award Date: Jan 1 1991

Research Area Keywords

  • Cancer
  • Clinical Translation & Trials
  • Clinical Care

Free-text keywords

  • Cancer research
  • Lung cancer
  • Targeted therapeutics

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

  • Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

    COVID-19 and Cancer Consortium, Jun 20 2020, In : The Lancet. 395, 10241, p. 1907-1918 12 p.

    Research output: Contribution to journalArticle

  • 37 Scopus citations

    Clinical Utility of Reflex Ordered Testing for Molecular Biomarkers in Lung Adenocarcinoma

    Anand, K., Phung, T. L., Bernicker, E. H., Cagle, P. T., Olsen, R. J. & Thomas, J. S., Jan 1 2020, In : Clinical Lung Cancer.

    Research output: Contribution to journalArticle

  • Combined blockade of activating ERBB2 mutations and ER results in synthetic lethality of ERþ/HER2 mutant breast cancer

    Croessmann, S., Formisano, L., Kinch, L. N., Gonzalez-Ericsson, P. I., Sudhan, D. R., Nagy, R. J., Mathew, A., Bernicker, E. H., Cristofanilli, M., He, J., Cutler, R. E., Lalani, A. S., Miller, V. A., Lanman, R. B., Grishin, N. V. & Arteaga, C. L., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 277-289 13 p.

    Research output: Contribution to journalArticle

  • 11 Scopus citations